IntelliCell manufactures SVF cells from non-living donated adipose tissue
The cells have been grown in culture and have the correct CD antibody markers for mesenchymal stem cells and other cells that are consistent with SVF cells. SVF
The European Commission (EC) has approved an extended use of Johnson & Johnson’s Tecvayli (teclistamab), along with daratumumab, to treat adult patients with relapsed or refractory multiple myeloma (r/r MM).